Based on SEC filing data. A corporation founded in 2015 and based in Lexington, MA, raised $56.0 million in an equity round while in growth stage.
Get notified the moment Keros Therapeutics, Inc. (KROS) files a new round, hires execs, or shows traction signals.
Create free accountAbout this data
FlareSight surfaces funding data from SEC Form D filings within hours of submission. Browse our full startup funding database to find more recently funded companies.